← Leaderboards
Jane B Alavi
University Of Pennsylvania
$1,520,103
Attributed
$1,520,103
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,520,103 · 6
By mechanism
M01$1,418,468 · 5
U01$101,635 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Donald M Coen$28,460,204
- Priscilla A Schaffer$9,603,836
- Nigel William Fraser$9,701,410
- Jay Fitzgerald Dorsey$6,888,388
- Roselyn J. Eisenberg$9,818,286
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchNeoplasm /Cancer ChemotherapyHuman SubjectHuman Therapy EvaluationClinical Trial Phase IPharmacokineticsAntineoplasticsOral AdministrationDrug Screening /EvaluationGlioblastoma MultiformeCentral Nervous System NeoplasmsAnalogCarboxylateAstrocytomaCamptothecinDrug Adverse EffectPyrazolopyrimidineDrug Administration Rate /DurationDosageNeoplastic ProcessAnticonvulsantsProcarbazineNeoplasm /Cancer TherapyBrain Neoplasms
Grant awards (28)
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME$124,146
M01 · FY2002 · RR
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA$124,146
M01 · FY2002 · RR
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE$124,146
M01 · FY2002 · RR
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO$124,146
M01 · FY2002 · RR
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA$124,146
M01 · FY2001 · RR
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO$124,146
M01 · FY2001 · RR
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME$124,146
M01 · FY2001 · RR
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE$124,146
M01 · FY2001 · RR
NEW APPROACHES TO BRAIN TUMOR THERAPY--A CNS CONSORTIUM$101,635
U01 · FY2001 · CA
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA$0
M01 · FY2001 · RR
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME$0
M01 · FY2001 · RR
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO$0
M01 · FY2001 · RR
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE$0
M01 · FY2001 · RR
PHASE 1 TRIAL OF HSVTK GENE THERAPY FOR CNS TUMORS$187,536
M01 · FY2000 · RR
PHASE 1 TRIAL OF HSVTK GENE THERAPY FOR CNS TUMORS$187,536
M01 · FY2000 · RR
PHASE 1 TRIAL OF HSVTK GENE THERAPY FOR CNS TUMORS$25,114
M01 · FY2000 · RR
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE$25,114
M01 · FY2000 · RR
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA$0
M01 · FY2000 · RR
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE$0
M01 · FY2000 · RR
CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE 3 TIME DAILY SCHEDULE$0
M01 · FY2000 · RR
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO$0
M01 · FY2000 · RR
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA$0
M01 · FY2000 · RR
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME$0
M01 · FY2000 · RR
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO$0
M01 · FY2000 · RR
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO$0
M01 · FY2000 · RR
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME$0
M01 · FY2000 · RR
UPCC8399: ORAL PROCARBAZINE IN TREATMENT OF RECURRENT HIGH GRADE ASTROCYTOMA$0
M01 · FY2000 · RR
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME$0
M01 · FY2000 · RR